Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
about
Clinical importance of aspirin and clopidogrel resistanceNew aspects on efficient anticoagulation and antiplatelet strategies in sheep.Clinical evidence of interaction between clopidogrel and proton pump inhibitorsThe interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress.Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful?Aspirin and clopidogrel resistance: methodological challenges and opportunities.Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.Emerging antiplatelet agents, differential pharmacology, and clinical utility.Evolving role of platelet function testing in coronary artery interventions.Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.Profiling and Preparation of Metabolites from Pyragrel in Human Urine by Online Solid-Phase Extraction Coupled with High Performance Liquid Chromatography Tandem Mass Spectrometry Followed by a Macroporous Resin-Based Purification Approach.Vascular and platelet responses to aspirin in patients with coronary artery disease.Investigation of drug-drug interactions between clopidogrel and fluoxetine.
P2860
Q34390050-EBE1FD05-E7FD-496F-AAB9-56B3BF0C9788Q35006714-F2E43F89-8142-414F-B62F-BAF49608CFF3Q35033722-C61E37B1-84E0-4E6D-990A-43A5D652F222Q35683944-895417EC-25A7-4955-8300-486909967AB6Q35792726-DF311E54-59D7-4F52-9B21-135E384EEDFDQ36160606-4F4F696A-E6AE-4547-9DF6-F5955D160170Q37387416-8226E2B0-61B9-48C7-9909-EF075897CFAFQ37744524-E26FD51F-7C76-410A-BA14-A49C615699B5Q37801291-1E353DC3-48A5-40CC-B5B8-0E6213F24B83Q37979178-18F078C2-FED6-4FFB-9AB3-D424DD376E3CQ37988850-59CF3035-7143-4646-BD90-2A6CAAFA529AQ38197732-F7C8D1DA-7B50-42F0-9F9B-B919F8B9DCF4Q38881868-AC287E95-6C0C-4513-ACBE-B66CAD821A39Q43970520-FDFE0BB7-8FBA-4D6E-82E0-30D21EE1834BQ45332852-C21B3B23-964B-40B0-B1A2-B0AE429704D8
P2860
Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@en
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@nl
type
label
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@en
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@nl
prefLabel
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@en
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@nl
P2093
P2860
P921
P356
P1476
Aspirin and clopidogrel hypore ...... with coronary artery stenting.
@en
P2093
Donald J Voelker
Girish Bhatt
Hanumanth K Reddy
Rakesh K Sharma
Rohit Sharma
Vibhuti N Singh
P2860
P304
P356
10.2147/VHRM.S6787
P407
P577
2009-11-16T00:00:00Z